SAFETY, AND TOLERABILITY
Clinical trials for SAFETY, AND TOLERABILITY explained in plain language.
Never miss a new study
Get alerted when new SAFETY, AND TOLERABILITY trials appear
Sign up with your email to follow new studies for SAFETY, AND TOLERABILITY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New inhaled migraine treatment shows promise in early trial
Knowledge-focused CompletedThis early-stage study tested a new inhaled powder form of the migraine drug dihydroergotamine (DHE) in 44 healthy adults. Researchers compared how the body absorbs the drug when inhaled versus when given as a nasal spray or injection. The goal was to check safety and measure dru…
Matched conditions: SAFETY, AND TOLERABILITY
Phase: PHASE1 • Sponsor: Aspeya Switzerland SA • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC
-
12 healthy volunteers test drug combo in Early-Stage study
Knowledge-focused CompletedThis early-stage study looked at how a new GERD drug, linaprazan glurate, changes the way the body processes the antibiotic amoxicillin. Twelve healthy adults took amoxicillin alone and then again after a week of the GERD drug. The goal was to measure drug levels in the blood, no…
Matched conditions: SAFETY, AND TOLERABILITY
Phase: PHASE1 • Sponsor: Cinclus Pharma Holding AB • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC
-
New antibody AK1967 tested in healthy men as potential shock therapy
Knowledge-focused CompletedThis Phase 1 study tested the safety and tolerability of a single intravenous dose of AK1967 (Procizumab) in 24 healthy male volunteers. AK1967 is an antibody that blocks a protein called DPP3, which may worsen blood pressure drops during cardiogenic shock. The study only looked …
Matched conditions: SAFETY, AND TOLERABILITY
Phase: PHASE1 • Sponsor: 4TEEN4 Pharmaceuticals GmbH • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:08 UTC